Here, we have used these Eμ-Myc models to identify two compensatory bypass signalling pathways used by Eμ-Myc lymphomas for continued growth, proliferation and survival in the absence of optimal ATR–CHK1 signalling. The gene discussed is CHEK1; the disease is lymphoma.